This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
October 11, 2018
Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City today, 11 October, 2018
October 09, 2018
Rights issue in Vicore oversubscribed by 33 percent – The company receives SEK 82.4M
October 08, 2018
Altimmune Announces $25 million Registered Direct Offering
October 08, 2018
BONESUPPORT to Showcase CERAMENT® BONE VOID FILLER at Two Upcoming US Orthopedic Conferences
October 08, 2018
Orexo appoints Nomination Committee and publishes financial calendar 2018/2019
October 04, 2018
Targovax to Host Capital Markets Day 15 October 2018, in Oslo, Norway
October 03, 2018
Altimmune Closes on $16.9 Million in Funding
October 02, 2018
Nordic Nanovector: Abstracts of LYMRIT 37-01 Study with Betalutin® in NHL Patients and other Studies accepted for poster presentations at ASH
October 01, 2018
Targovax presented ONCOS-102 poster at 13th International Adenovirus Meeting
October 01, 2018
Orexo internalizes contract field force in the US to further strengthen the commercial organization